Supriya Lifescience Limited
Supriya Lifescience Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the production of active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a strong focus on quality and innovation, Supriya Lifescience offers a diverse range of products, including anti-allergic, anti-inflammatory, and anti-viral APIs. Their commitment to research and development has led to significant advancements, positioning them as a trusted supplier in the global pharmaceutical landscape. Notably, the company has achieved several milestones, including regulatory approvals from major international health authorities, further solidifying its reputation for excellence in the industry.
DitchCarbon Score
How does Supriya Lifescience Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Supriya Lifescience Limited's score of 28 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Supriya Lifescience Limited's reported carbon emissions
In 2024, Supriya Lifescience Limited reported significant carbon emissions, with Scope 1 emissions totalling approximately 16,125,000 kg CO2e and Scope 2 emissions reaching about 66,760,000 kg CO2e. This data reflects the company's operational footprint within India, where it generated revenue of approximately USD 68,452,903. Comparatively, in 2023, the company recorded Scope 1 emissions of about 13,842,000 kg CO2e and Scope 2 emissions of approximately 74,188,000 kg CO2e, indicating a slight increase in Scope 1 emissions year-on-year. The global emissions data for 2023 showed Scope 1 emissions of around 490,206 kg CO2e and Scope 2 emissions of about 11,450,770 kg CO2e. Supriya Lifescience has not set specific reduction targets or climate pledges, nor does it report on Scope 3 emissions. The absence of reduction initiatives or commitments suggests a need for further development in their climate strategy. The company’s emissions data is not cascaded from any parent organisation, indicating that it operates independently in its reporting and sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 315,257 | 000,000 | 000,000 |
| Scope 2 | 8,643,810 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Supriya Lifescience Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
